“Every civilisation leaves behind two kinds of inheritance. One is memory. The other is knowledge. Memory tells us what our ancestors believed. Knowledge tells us what they actually discovered.”
For nearly a century, India has argued over one question that belongs in a laboratory, not on television.
Is gaumutra medicine? Or is it mythology?
Perhaps the real question is different. Why has India, the birthplace of Ayurveda, not conducted enough world-class research to settle this once and for all?
That may be the bigger story here.
The civilisation that observed nature
Long before microscopes and DNA sequencing, Indian physicians studied the human body with extraordinary patience.
The Charaka Samhita discussed diagnosis, digestion and immunity. The Sushruta Samhita described surgical techniques centuries ahead of their time.
Some of these ancient observations have since found support in modern science. Others have not, and that is not unusual. Greek, Chinese and Persian medical traditions faced the same fate.
The achievement of a civilisation was never that every ancient idea proves correct. It is that later generations find the courage to test those ideas honestly.
Science does not care where an idea was born
Many people imagine a battle between Ayurveda and modern medicine. In reality, the two can work together.
Science does not ask where an idea originated. It asks whether the idea survives testing. A compound from a rainforest plant, a marine sponge, or an Ayurvedic formulation — all enter the laboratory under the same rules.
Evidence decides. Not geography, not sentiment.
This is exactly why many modern medicines trace their roots to traditional knowledge. Tradition often provides the clue. Science determines whether that clue becomes a genuine therapy.
India’s missed opportunity and a quiet head start
India holds one of the richest repositories of traditional medical knowledge in the world. Yet few formulations have gone through large, internationally recognised clinical trials.
There is already a real example worth knowing. India’s Council of Scientific and Industrial Research holds US patents on cow urine distillate — but not for curing cancer. The patents recognise it as a “bio-enhancer,” a substance that may boost how the body absorbs certain antibiotics and drugs, based on laboratory findings.
That distinction matters. A patent on enhancing drug absorption is not the same as proof of a cure. But it does show that rigorous science and traditional knowledge can meet on neutral ground when the research is done properly.
Encouragingly, the country now has the beginnings of that infrastructure. The Ministry of Ayush has signed a global strategy agreement with the World Health Organisation, set up a research portal cataloguing over 43,000 studies, and is expanding the WHO’s Global Traditional Medicine Centre in Jamnagar into a full international research campus.
The intent exists. What it produces over the next decade will matter far more than any headline today.
Why the Debate Never Ends
The gaumutra debate survives because two separate conversations happen at once.
One is about faith. The other is about medicine.
Faith asks whether a practice holds cultural or spiritual meaning. Science asks whether it safely treats a specific disease. These questions do not have to compete.
A person can respect the cow deeply and still expect clinical evidence before accepting a medical claim. Confusing the two conversations has generated far more heat than light.
What would convince the world
Imagine a pharmaceutical-grade preparation derived from cow urine goes through full standardisation, toxicology testing, and multiple phases of human trials, with results independently replicated abroad.
Would leading medical journals ignore it simply because it came from India? History says no. Science has repeatedly accepted discoveries from every region, provided the evidence held up.
The burden was never nationality. It has always been proof.
Everyone has a part to play
Researchers carry the responsibility of guarding against their own bias, whether that bias leans toward belief or toward dismissal. Transparent data and independent review protect science from both extremes.
The media has often failed this story, choosing headlines that either declare a miracle cure or mock the idea outright. Neither headline explains what was actually studied, on how many people, or whether it was replicated.
Believers in tradition should welcome scrutiny rather than fear it. If a therapy works, honest research strengthens it. If a claim is wrong, letting it go protects the credibility of everything else in the tradition.
Sceptics, too, have a duty. Dismissing every traditional remedy without investigation is its own form of unscientific thinking. The correct response to an unfamiliar claim is research, not ridicule.
What India should do next
A national programme could identify the most promising traditional formulations and test them against the highest global standards, publishing results openly regardless of outcome.
If a formulation works, India gains genuine recognition. If it does not, the record becomes clearer. Either result moves knowledge forward and that is how confident civilisations behave.
This series was never meant to persuade readers to consume gaumutra, or to reject it.
Its purpose was simpler: intellectual honesty.
Existing research has identified biologically interesting properties in cow urine and its distillate that are worth continued study. But the current body of high-quality clinical evidence is not enough to call gaumutra a proven treatment for major diseases like cancer, diabetes, or viral infections.
That conclusion should not disappoint anyone. It should push India toward better laboratories, better trials, and better evidence.
Because in the end, faith can preserve a tradition. Only evidence can turn it into medicine.
Subscribe Deshwale on YouTube
